Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Methylprednisolone × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Down Syndrome 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trametinib 1 etoposide phosphate 1 erdafitinib 1 ensartinib 1 dabrafenib 1 Sirolimus 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡